Literature DB >> 29926111

Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations.

Benjy Yi-Min Soh1,2, Rajneesh Kumar1,2, Victoria Sze-Min Ekstrom1,2, Clement Yi-Hao Lin1, Sobhana Thangaraju2,3, Hwee Huang Tan4, Kwai Peng Chan2,5, Lina Hui Lin Choong2,3, Diana Teo4, Wan Cheng Chow1,2.   

Abstract

INTRODUCTION: To study the prevalence of hepatitis C virus (HCV) infection in blood donor (BD), haemodialysis (HD) and intravenous drug user (IVDU) populations in Singapore and assess the IL28B polymorphism if HCV positive.
METHODS: The BD population were healthy volunteers, the HD population were patients who were on haemodialysis for at least six months of follow-up between January 2009 and December 2014. IVDU population was from inmates at halfway houses who consented.
RESULTS: Between 2011 and 2014, of 161,658 individuals who underwent screening prior to blood donation, 95 (0.059%) were positive for HCV. Of the 42 sera available, common genotypes (GTs) were GT-3 (47.6%) and GT-1 (31.0%). Of 1,575 HD patients, 2.2% were anti-HCV positive. The HCV GT distribution was HCV GT-1 (32.4%), HCV GT-3 (20.5%) and GT-6 (8.8%). 83 halfway house inmates were screened. Of the 47 IVDUs, 36.2% were anti-HCV positive with predominant GT-3 (%). IL28B polymorphism was noted to be CC predominantly 85.3%.
CONCLUSION: Prevalence of HCV infection has decreased in both the BD and HD populations. However, it remains high in the IVDU population. GT-1 remains the most common in the HD population; however, GT-3 infection is now more common among the BD population in Singapore. IL28B - CC is the predominant variant among the HCV-infected individuals in Singapore. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  HCV genotype; IL28B; Singapore; hepatitis C; prevalence

Mesh:

Substances:

Year:  2018        PMID: 29926111      PMCID: PMC6351688          DOI: 10.11622/smedj.2018078

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  20 in total

1.  KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease.

Authors: 
Journal:  Kidney Int Suppl       Date:  2008-04       Impact factor: 10.545

2.  Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore.

Authors:  P Kuperan; A T Choon; S H Ding; G Lee
Journal:  Southeast Asian J Trop Med Public Health       Date:  1993       Impact factor: 0.267

3.  The hepatitis C virus epidemic among injecting drug users.

Authors:  Oliver G Pybus; Alexandra Cochrane; Edward C Holmes; Peter Simmonds
Journal:  Infect Genet Evol       Date:  2005-03       Impact factor: 3.342

Review 4.  Hepatitis C virus infection and the dialysis patient.

Authors:  Fabrizio Fabrizi; Giovanna Lunghi; Sri Venkatesh Ganeshan; Paul Martin; Piergiorgio Messa
Journal:  Semin Dial       Date:  2007 Sep-Oct       Impact factor: 3.455

Review 5.  Global estimates of prevalence of HCV infection among injecting drug users.

Authors:  Carmen Aceijas; Tim Rhodes
Journal:  Int J Drug Policy       Date:  2007-08-07

6.  Treatment responses in Asians and Caucasians with chronic hepatitis C infection.

Authors:  Kenneth-K Yan; Marianne Guirgis; Thuy Dinh; Jacob George; Anouk Dev; Alice Lee; Amany Zekry
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

7.  Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore.

Authors:  M Winslow; M Subramaniam; W L Ng; A Lee; G Song; Y H Chan
Journal:  Singapore Med J       Date:  2007-06       Impact factor: 1.858

8.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.

Authors:  Dongliang Ge; Jacques Fellay; Alexander J Thompson; Jason S Simon; Kevin V Shianna; Thomas J Urban; Erin L Heinzen; Ping Qiu; Arthur H Bertelsen; Andrew J Muir; Mark Sulkowski; John G McHutchison; David B Goldstein
Journal:  Nature       Date:  2009-08-16       Impact factor: 49.962

9.  Epidemiology of hepatitis C virus (HCV) infection.

Authors:  Theodore Sy; M Mazen Jamal
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

10.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

View more
  3 in total

Review 1.  Systematic Review of Hepatitis C Virus Prevalence in the WHO Western Pacific Region.

Authors:  Jenny Iversen; Handan Wand; Po-Lin Chan; Linh-Vi Le; Lisa Maher
Journal:  Viruses       Date:  2022-07-15       Impact factor: 5.818

2.  What is required for achieving hepatitis C virus elimination in Singapore? A modeling study.

Authors:  Antoine Chaillon; Prem Harichander Thurairajah; John Chen Hsiang; Natasha K Martin
Journal:  J Gastroenterol Hepatol       Date:  2020-09-03       Impact factor: 4.029

3.  Failure of sterilization in a dental outpatient facility: Investigation, risk assessment, and management.

Authors:  N Chanchareonsook; M L Ling; Q X Sim; K H Teoh; K Tan; B H Tan; K Y Fong; C Y Poon
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.